B
Bal Pharma Ltd
NSE:BALPHARMA
Bal Pharma Ltd
NSE:BALPHARMA
Price:
67.9
INR
0.09%
Market Closed
Market Cap:
₹1.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Bal Pharma Ltd
NSE:BALPHARMA
|
IN |
|
B
|
Berli Jucker PCL
SET:BJC
|
TH |
|
Grifols SA
MAD:GRF
|
ES |
|
Aptech Ltd
NSE:APTECHT
|
IN |
|
Sanki Engineering Co Ltd
TSE:1961
|
JP |
|
A
|
American Aires Inc
CNSX:WIFI
|
CA |
|
W
|
Widad Group Bhd
KLSE:WIDAD
|
MY |
|
Beijing Compass Technology Development Co Ltd
SZSE:300803
|
CN |
|
R
|
Retailors Ltd
TASE:RTLS
|
IL |
Relative Value
The Relative Value of one BALPHARMA stock under the Base Case scenario is hidden INR. Compared to the current market price of 67.9 INR, Bal Pharma Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BALPHARMA Relative Value
HIDDEN
Multiples Across Competitors
BALPHARMA Competitors Multiples
Bal Pharma Ltd Competitors
Bal Pharma Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
B
|
Bal Pharma Ltd
NSE:BALPHARMA
|
1.1B INR | 0.4 | 15.1 | 4.4 | 6.6 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
856.7B USD | 13.1 | 41.5 | 28 | 29.9 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.8B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 3.9 | 18.6 | 11.1 | 12.5 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
215.5B GBP | 4.9 | 28.1 | 15.6 | 22 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
282.6B USD | 4.3 | 15.5 | 9.6 | 11.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
221.8B CHF | 5.1 | 20.5 | 12.7 | 16.3 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.1T DKK | 3.4 | 10.3 | 7.6 | 8.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.4B USD | 2.5 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.7B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
